Both in Diagnostics
Insight Molecular Diagnostics vs Immucell
Over the past year IMDX returned +4.6% and ICCC returned +60.8%; their daily moves had a correlation of 0.04.
IMDX +4.6% ICCC +60.8%Growth of $1, one year, split-adjusted
| Metric | IMDX | ICCC |
|---|---|---|
| Price | $3.38 | $9.94 |
| Market cap | $110.6M | $90.3M |
| Today | +6.29% | +0.61% |
| 1 month | −18.2% | 0.0% |
| 6 months | +32.5% | +54.6% |
| Year to date | −54.9% | +61.6% |
| 1 year | +1.5% | +64.8% |
| Revenue growth (YoY) | −53.9% | +11.5% |
| Gross margin | 65.7% | 33.9% |
| Net margin | −4711.3% | 25.5% |
| P/E (TTM) | — | 114.7× |
| Price / sales | 66.2× | 2.9× |
| Net cash | $17.8M | $557.3K |
| Dividend yield | — | — |
| Volatility (60d) | 94.6% | 40.3% |
| Short % of float | 3.9% | 0.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).